{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5202",
      "entity_text" : "serotonin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00424",
      "entity_text" : "TPH2 inhibitor",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with the TPH2 inhibitor PCPA, which reduces serotonin synthesis and release, increased uptake of leptin in both the hypothalamus and brainstem, providing evidence that serotonin not only regulates leptin release, but also its uptake into the brain.",
  "reading_complete" : "2020-08-05T18:59:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T18:56:46Z",
  "trigger" : "reduces",
  "evidence" : [ "TPH2 inhibitor PCPA, which reduces serotonin" ],
  "pmc_id" : "3608917",
  "score" : 0
}